ALERT: Centralized Immunization Module now required for MEDITECH facilities at MU3 – we can help with your conversion – contact us now!

The IN Group is now part of DrFirst.

Press Release About DrFirst

Innovations in information technology moving IT outside the box.

The IN Group, Inc., offers information systems and workflow redesign consulting services, dealing exclusively with MEDITECH applications. Services incorporate an expertise in Project Management, Pharmacy and Advanced Clinical offerings, specializing in patient safety optimization.

Implementation, Optimization, and Upgrade Services

The IN Group offers a full range of services to assist your organization with any of your implementation or upgrade needs.

Learn More ▸

Meditech Report Writing

Our reporting services can help your organization get the most out of your Meditech system.

Learn More ▸

Other Vendor Implementation & Integration

The IN Group works with leading vendors to create integrated healthcare solutions.

Learn More ▸

Regulatory Services

Whether preparing for ICD-10 or attesting for Meaningful Use (MU),The IN Group can assist you in achieving your goals.

Learn More ▸

Support Services

Whether your organization requires interim CIO, or IT Staff, The IN Group can provide you with seamless coverage.

Learn More ▸

Our Expertise

The IN Group, Inc. is committed to providing quality, professional consulting services to health care organizations. Our goal is to help an organization manage their HCIS, comply with regulations, improve quality of patient care and manage resources effectively.

Learn More ▸

Meditech Rules

Acetaminophen 24 hour rule

eMAR rule – multiple medications may contain acetaminophen as a component. Acetaminophen dosage should be monitored and limited in any 24 hour period. By utilizing a query on the drug CDS that contains the amount of acetaminophen in the specific drug, a rule can be built to calculate the accumulative acetaminophen dose a patient has […]

Read more
In The News

JW Modifier Discussion

The new JW Modifier regulation is explained and issues discussed in this short screencast from one of our consultants and Meditech subject matter experts. Contact The IN Group for additional information or questions? ​

Read More ▸